Integra LifeSciences Holdings CorporationIARTNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank79
3Y CAGR+2.0%
5Y CAGR+2.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+2.0%/yr
vs -1.9%/yr prior
5Y CAGR
+2.1%/yr
Consistent
Acceleration
+3.9pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $776.92M | -9.0% |
| 2024 | $853.65M | +10.4% |
| 2023 | $773.21M | +5.7% |
| 2022 | $731.39M | -2.1% |
| 2021 | $747.41M | +6.8% |
| 2020 | $699.66M | -18.6% |
| 2019 | $859.12M | +8.8% |
| 2018 | $789.95M | +11.6% |
| 2017 | $707.92M | +34.2% |
| 2016 | $527.65M | - |